Sales & Marketing News | pharmaphorum

News

Pressure relieved on AZ as details of Chinese probe emerge

AstraZeneca's exposure to liability in a Chinese investigation into illegal drug imports appears to be much less than had been feared.

News

Newel's VR therapy for chronic pain nears EU market

Newel Health has been granted EU certification for its VR-based digital therapeutic for chronic pain, clearing the way for its launch in Europe.

News

Pharma group slams Hims & Hers over Super Bowl GLP-1 ad

Partnership for Safe Medicines claims the Hims & Hers ad for compounded weight-loss drug semaglutide, due to run during the Super Bowl, is "reckless."

News

Graphic representation of an implant into an eyeball

FDA expands label for Roche's eye disease implant Susvimo

The renaissance of Roche's refillable ophthalmic implant Susvimo has continued with FDA approval for use in patients with diabetic macular oedema.

News

Liva buys Momenta to bolster digital health platform

Liva Healthcare has acquired Momenta to create one of the largest providers of digital healthy lifestyle services to the NHS in England.

News

Novo rises on Wegovy sales leap, but warns of a slowdown

Novo Nordisk is expecting greater competition and pricing pressure in the obesity and diabetes sectors this year.

Pressure relieved on AZ as details of Chinese probe emerge

Newel's VR therapy for chronic pain nears EU market

Pharma group slams Hims & Hers over Super Bowl GLP-1 ad

FDA expands label for Roche's eye disease implant Susvimo

Liva buys Momenta to bolster digital health platform

Novo rises on Wegovy sales leap, but warns of a slowdown

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks